# Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer

> **NCT01344837** · — · COMPLETED · sponsor: **Gynecologic Oncology Group** · enrollment: 360 (actual)

## Conditions studied

- Endometrial Serous Adenocarcinoma
- Stage I Uterine Corpus Cancer
- Stage II Uterine Corpus Cancer
- Stage III Uterine Corpus Cancer
- Stage IV Uterine Corpus Cancer

## Interventions

- **OTHER:** Diagnostic Laboratory Biomarker Analysis
- **OTHER:** Immunohistochemistry Staining Method
- **OTHER:** Medical Chart Review
- **GENETIC:** Microarray Analysis
- **OTHER:** Study of Socioeconomic and Demographic Variables
- **GENETIC:** Western Blotting

## Key facts

- **NCT ID:** NCT01344837
- **Lead sponsor:** Gynecologic Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-01
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2024-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01344837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01344837, "Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01344837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*